Abstract
There are diverse demands influencing the availability of medicinal products. Physicians and patients search for the best available individualised pharmacotherapy.
Health care systems as well as medicine producers search for the most effective ways of resource allocation. Those are reasons why, especially in the case of a small market such as Czech Republic, some pharmaceuticals may not be directly available.
However, there are ways to acquire such medications. This article describes a legal framework for the use of non-authorised medicinal products in the Czech Republic and some examples from every day practise.